Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Financial Markets Consulting Regulatory News (AFM)

Share Price Information for Alpha Financial Markets Consulting (AFM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 497.00
Bid: 496.00
Ask: 498.00
Change: 1.00 (0.20%)
Spread: 2.00 (0.403%)
Open: 497.00
High: 497.00
Low: 496.00
Prev. Close: 496.00
AFM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Market Consulting plc

24 May 2024 10:30

Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Market Consulting plc 24-May-2024 / 10:30 GMT/BST


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Chelverton Asset Management

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

ALPHA FINANCIAL MARKET CONSULTING PLC, Ordinary

(ISIN: GB00BF16C058)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

Opening position disclosure as at

24 May 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary 0.075p

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,120,731

 

1.74

N/A

 

(2) Cash-settled derivatives:

 

N/A

-

N/A

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

-

N/A

 

 

 TOTAL:

2,120,731

 

1.74

N/A

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

24 May 2024

Contact name:

Apex Fund Administration Services (UK) Limited

Telephone number*:

01245 398950

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
Category Code:RET - Alpha Financial Market Consulting plc
TIDM:MISL
LEI Code:549300P2JF82DYWEXW33
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:323819
EQS News ID:1910853
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Apr 20217:00 amRNSPre-close trading update
16th Mar 202112:00 pmEQSEdison Investment Research Limited: Alphamin Resources (AFM): Initiation -⁠ Alpha tin actually
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSCapital Markets Presentation
18th Feb 20217:00 amRNSExercise of awards and total voting rights
26th Jan 20217:00 amRNSAppointment of Nominated Adviser
14th Jan 20217:00 amRNSGrant of incentive awards and total voting rights
7th Jan 202112:37 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSINTERIM RESULTS
5th Nov 20207:00 amRNSAppointment of Joint Broker
4th Nov 20209:00 amRNSNotice of interim results
29th Oct 20207:00 amRNSAlpha FMC launches dedicated ESG & RI practice
15th Oct 20207:00 amRNSStaff Incentive Awards and PDMR Shareholding
8th Oct 20207:00 amRNSPre-close trading update
23rd Sep 202012:28 pmRNSResult of AGM
23rd Sep 20208:36 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSAnnual Report, Notice of AGM and Board change
23rd Jul 20207:16 amRNSStaff Incentive Awards and PDMR Shareholding
24th Jun 20207:00 amRNSFull Year Results
22nd Jun 20207:00 amRNSNon-Executive Director appointment
12th Jun 20209:49 amRNSNotice of Full Year Results
18th May 20203:12 pmRNSHolding(s) in Company
11th May 202011:15 amRNSHolding(s) in Company
9th Apr 20207:00 amRNSPre-close trading update
1st Apr 20209:12 amRNSHolding(s) in Company
24th Mar 20207:00 amRNSStatement regarding COVID-19
14th Jan 202012:00 pmRNSGrant of incentive awards and total voting rights
2nd Dec 20199:16 amRNSHolding(s) in Company
29th Nov 201911:46 amRNSHolding(s) in Company
25th Nov 20194:19 pmRNSHolding(s) in Company
22nd Nov 20199:50 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSINTERIM RESULTS
11th Nov 20197:00 amRNSAcquisition of Obsidian Solutions Limited
28th Oct 20198:53 amRNSHolding(s) in Company
24th Oct 201910:27 amRNSHolding(s) in Company
24th Oct 201910:22 amRNSHolding(s) in Company
9th Oct 20197:00 amRNSPre-close trading update
4th Sep 20193:30 pmRNSAGM Statement
5th Aug 20193:37 pmRNSAnnual Report & Accounts and Notice of AGM
24th Jul 20194:00 pmRNSHolding(s) in Company
10th Jul 20195:30 pmRNSHolding(s) in Company
21st Jun 20192:30 pmRNSHolding(s) in Company
19th Jun 20197:00 amRNSStaff Incentive Awards and PDMR Shareholding
5th Jun 20197:15 amRNSAcquisition of Axxsys Limited
5th Jun 20197:00 amRNSFinal Results
3rd Jun 201910:00 amRNSNotice of Results - updated presentation time
11th Apr 20197:00 amRNSPre-close trading update
25th Jan 20198:00 amRNSGrant of incentive awards and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.